
News|Videos|December 13, 2016
Treatment Approaches for Therapy-Related AML, MDS Based on Mutation Profiles
Author(s)Michael Heuser, MD
This video examines different mutational profiles of therapy-related myeloid neoplasms and how they can affect approaches to treatment.
Advertisement
In this video, Michael Heuser, MD, of the Hannover Medical School in Germany, discusses different mutational profiles of therapy-related myeloid neoplasms, such as acute myeloid leukemia (AML) and myelodysplastic syndromes, and how these genetic profiles can affect approaches to treatment.
Dr. Heuser spoke at an education session on AML at the 58th Annual Meeting of the American Society of Hematology, held December 3–6 in San Diego, California.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Orphan Drug Designation to Tovecimig for Biliary Tract Cancer
2
Relacorilant/Nab-Paclitaxel Reduces Risk of Death by 35% in Platinum-Resistant Ovarian Cancer
3
Lesions in Radiated/Non-Radiated Fields Achieve Similar Responses with Tisotumab Vedotin in Cervical Cancer
4
Cemiplimab Exhibits Long-Term Clinical Benefit in Advanced NSCLC Trial
5




















































